Literature DB >> 9058198

The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells.

K Yanagisawa1, Y Naito, K Kuroiwa, T Arai, Y Furukawa, H Tomizuka, Y Miura, T Kasahara, T Tetsuka, S Tominaga.   

Abstract

The ST2 gene, which is specifically induced by growth stimulation, encodes interleukin-1 receptor-related proteins. Using the RT-PCR method, we found that the ST2 gene was broadly expressed in hematopoietic cell lines. It was also expressed specifically in helper T cell lines among lymphocytic cell lines. We analyzed the expression of ST2 in mouse helper T cell subsets with Northern blotting analysis. Mouse Th1 cell lines so far studied did not express ST2 mRNAs. On the other hand, one of the Th2 cell lines, D10, expressed ST2L (transmembrane form) without stimulation, while co-stimulation by PMA and A23187 induced ST2 (soluble form) mRNA. These results suggest that the ST2 gene is involved in the regulation of the immune system. IL-1 alpha, IL-1 beta, and receptor antagonist did not bind to ST2L protein, which prompted us to search for the specific ligand of ST2. The recombinant human ST2 protein was purified and labeled with FITC. The labeled human ST2 protein bound with myeloma-derived RPMI8226 cells among the various B-cell lines, indicating possible involvement of ST2 in T-cell/B-cell interaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058198     DOI: 10.1093/oxfordjournals.jbchem.a021577

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  25 in total

Review 1.  The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders.

Authors:  H E Barksby; S R Lea; P M Preshaw; J J Taylor
Journal:  Clin Exp Immunol       Date:  2007-06-21       Impact factor: 4.330

2.  ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells.

Authors:  Shinsuke Aoki; Morisada Hayakawa; Hiromi Ozaki; Naoki Takezako; Hiroto Obata; Nobuhiro Ibaraki; Tadahiko Tsuru; Shin-Ichi Tominaga; Ken Yanagisawa
Journal:  Mol Cell Biochem       Date:  2009-09-12       Impact factor: 3.396

3.  A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK).

Authors:  Ken Yanagisawa; Kenji Tago; Morisada Hayakawa; Motomichi Ohki; Hiroyuki Iwahana; Shin-Ichi Tominaga
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 4.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

5.  Global transcriptional response to carbonic anhydrase IX deficiency in the mouse stomach.

Authors:  Heini Kallio; Mika Hilvo; Alejandra Rodriguez; Eeva-Helena Lappalainen; Anna-Maria Lappalainen; Seppo Parkkila
Journal:  BMC Genomics       Date:  2010-06-23       Impact factor: 3.969

6.  Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.

Authors:  Jozef Bartunek; Leen Delrue; Frederik Van Durme; Olivier Muller; Filip Casselman; Bart De Wiest; Romaric Croes; Sofie Verstreken; Marc Goethals; Herbert de Raedt; Jaydeep Sarma; Lija Joseph; Marc Vanderheyden; Ellen O Weinberg
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

7.  T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.

Authors:  M Löhning; A Stroehmann; A J Coyle; J L Grogan; S Lin; J C Gutierrez-Ramos; D Levinson; A Radbruch; T Kamradt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.

Authors:  Markus Brunner; Claus Krenn; Georg Roth; Bernhard Moser; Martin Dworschak; Erika Jensen-Jarolim; Andreas Spittler; Thomas Sautner; Nico Bonaros; Ernst Wolner; George Boltz-Nitulescu; Hendrik Jan Ankersmit
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

9.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Authors:  Mark T Vander Lugt; Thomas M Braun; Samir Hanash; Jerome Ritz; Vincent T Ho; Joseph H Antin; Qing Zhang; Chee-Hong Wong; Hong Wang; Alice Chin; Aurélie Gomez; Andrew C Harris; John E Levine; Sung W Choi; Daniel Couriel; Pavan Reddy; James L M Ferrara; Sophie Paczesny
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

10.  Elevated levels of soluble ST2 protein in dengue virus infected patients.

Authors:  Aniuska Becerra; Rajas V Warke; Norma de Bosch; Alan L Rothman; Irene Bosch
Journal:  Cytokine       Date:  2008-01-28       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.